PVLA Palvella Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 4, 2026
$132,47
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$61,73rendah 52m
$161,38tinggi 52m
Kapitalisasi Pasar (MRQ)
$1.91B
P/E
-35.7
EPS
$-3.71
Pendapatan
$43M
lencana Anda
Rentang 52M
$62–$161
Peringkat Analis
BUY
Target Harga
$231
P/E
-35.7
ROE
-110.1%
Margin Laba Bersih
-1610.6%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
PVLA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$132.47
Kapitalisasi Pasar (MRQ)
$1.91B
P/E
-35.7
EPS
$-3.71
Pendapatan
$43M
ROE
-110.1%
Rentang 52M
$62–$161
PVLA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 23 April 2024 | 1-for-80 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$43M2017-12-31 → 2023-12-31
EPS$-3.712020-12-31 → 2025-12-31
Arus Kas Bebas·2017-12-31 → 2022-12-31
Margin bersih-1610.6%2017-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | PVLA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -35.7rata-rata 5T ≈-113.6 | ≈-113.6 | · | · | |
| P/S | 83.8rata-rata 5T ≈104.1 | ≈104.1 | 25.9 | Terlalu mahal | |
| P/B (MRQ) | 8.8rata-rata 5T ≈90.1 | ≈90.1 | 5.4 | Terlalu mahal | |
| Price / Cash Flow (Harga / Arus Kas) | -65.6rata-rata 5T ≈-55.8 | ≈-55.8 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 58.6rata-rata 5T ≈159.6 | ≈159.6 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | PVLA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Operating Margin (Margin Operasi) | -1490.4% | · | -668.2% | Di bawah rata-rata | |
| EBITDA Margin (Margin EBITDA) | -1490.4% | · | -668.2% | Di bawah rata-rata | |
| Pretax Margin (Margin Sebelum Pajak) | -1610.6% | · | -765.9% | Lemah | |
| Net Profit Margin (Margin Laba Bersih) | -1610.6% | · | -669.0% | Di bawah rata-rata | |
| ROA | -56.5%rata-rata 5T ≈-39.9% | ≈-39.9% | -42.9% | Lemah | |
| ROE | -110.1%rata-rata 5T ≈-20.5% | ≈-20.5% | -60.0% | Lemah | |
| ROIC | -137.9%rata-rata 5T ≈-105.4% | ≈-105.4% | -62.3% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | PVLA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 21.2rata-rata 5T ≈4.8 | ≈4.8 | 6.0 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 5.1rata-rata 5T ≈4.6 | ≈4.6 | 4.4 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | PVLA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 65.3%rata-rata 5T ≈18.3% | ≈18.3% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 13.4% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | PVLA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0 | · | 0.1 | Lemah | |
| Receivables Turnover (Perputaran Piutang) | 14.5 | · | 4.6 | Tingkat teratas | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$1.5M | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-53.9%
Laporan Berikutnya
Nov 09, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 13, 2026 | $-1.52 | $-1.18 | -28.5% |
| 31 Maret 2026 | Mei 14, 2026 | $-1.20 | $-0.95 | -26.2% |
| 31 Des. 2025 | $-1.07 | $-0.93 | -15.2% | |
| 30 Sep. 2025 | $-1.03 | $-0.86 | -20.5% | |
| 30 Juni 2025 | $-0.86 | $-0.76 | -13.8% | |
| 31 Maret 2025 | $-0.74 | $-1.24 | 40.1% | |
| 31 Des. 2024 | $-2.72 | $-0.66 | -313.4% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| R&D Expense | $23M | $8M | $9M | $53M | $67M | $47M | $55M | $41M | $22M | $20M | $8M | $6M | |
| SG&A Expense | $16M | $6M | $3M | $16M | $17M | $17M | $18M | $18M | $18M | $9M | $8M | $7M | |
| Operating Expenses | $39M | $14M | $12M | $69M | $83M | $63M | $73M | $60M | $40M | $29M | $17M | $13M | |
| Operating Income | $-39M | $-14M | $-12M | $-43M | $-52M | $-34M | $-27M | $-31M | $-15M | $-23M | $-14M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Other Non-op | $727.0K | $-131.0K | $712.0K | $1M | $2M | $-4M | $-26.0K | $2M | $-2M | $120.0K | $10.9K | $3.0K | |
| Pretax Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-17M | $-23M | $-14M | $-10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $164.0K | $0 | $-312.0K | $1M | $162.0K | $203.9K | $-18 | |
| Net Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| EPS (Basic) | $-3.71 | $-7.83 | $2.19 | $-0.45 | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.71 | $-7.83 | $2.17 | · | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| Shares (Basic) | 11,251,250 | 2,225,934 | 1,770,167 | 74,172,000 | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 11,251,250 | 2,225,934 | 1,793,980 | · | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-14M | · | $-41M | · | $-34M | $-27M | $-31M | $-15M | · | · | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $84M | $7M | $39M | $118M | $70M | $62M | $75M | $38M | $29M | $29M | $18M | |
| Short-term Investments | $0 | · | $9M | $21M | $0 | $0 | $42M | $53M | $35M | $0 | · | · | |
| Receivables | $0 | $358.0K | $0 | $6M | $3M | $2M | $7M | $3M | $16M | $57.0K | $0 | $0 | |
| Prepaid Expense | $1M | $2M | $198.0K | $3M | $7M | $4M | $4M | $5M | $2M | $3M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $59M | $88M | $8M | $73M | $128M | $76M | $115M | $135M | $90M | $33M | $32M | $20M | |
| PP&E (Net) | · | · | $0 | $17M | $19M | $22M | $20M | $5M | $4M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | · | $27M | $27M | $28M | $23M | $8M | $7M | $5M | $4M | $4M | |
| Accum. Depreciation | · | · | · | $10M | $8M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $0 | $1M | $3M | $3M | $3M | $910.0K | $130.0K | $126.0K | $126.8K | · | |
| Total Assets | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Accounts Payable | $5M | $5M | $936.0K | $4M | $9M | $2M | $6M | $3M | $2M | $2M | $1M | · | |
| Accrued Liabilities | · | · | · | · | · | $8M | $10M | $9M | $6M | $4M | $2M | $986.6K | |
| Current Liabilities | $11M | $12M | $2M | $37M | $51M | $22M | $27M | $48M | $46M | $8M | $3M | $4M | |
| Capital Leases | $431.0K | $0 | $0 | $12M | $14M | $16M | $15M | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | $6.0K | $0 | $27.0K | $37.0K | $47.0K | $23.9K | $334.0K | |
| Total Liabilities | $32M | $26M | $11M | $68M | $103M | $74M | $90M | $101M | $92M | $10M | $3M | $4M | |
| Common Stock | $12.0K | $11.0K | $0 | $74.0K | $72.0K | $56.0K | $55.0K | $54.0K | $45.0K | $43.0K | $39.8K | $29.3K | |
| Paid-in Capital | $163M | $156M | $2M | $319M | $307M | · | · | · | · | · | $112M | $85M | |
| Retained Earnings | $-135M | $-94M | $-76M | $-290M | $-257M | $-211M | $-174M | $-147M | $-120M | $-103M | $-80M | $-66M | |
| AOCI | $83.0K | $3.0K | $0 | $-254.0K | $829.0K | $-295.0K | $-2M | $-3M | $-5M | $-2M | $-1M | $-843.1K | |
| Stockholders' Equity | $28M | $63M | $-74M | $-94M | $51M | $31M | $51M | $40M | $12M | $25M | $31M | $18M | |
| Liabilities + Equity | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Shares Outstanding | 12,380,933 | 11,012,105 | 1,770,167 | 74,519,103 | 72,222,661 | 56,003,000 | 55,212,437 | 54,151,219 | 45,017,062 | 43,058,827 | 39,833,023 | 29,279,522 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2M | $3M | $2M | · | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $830.0K | $603.0K | $4M | $5M | $5M | $5M | $5M | $3M | $2M | $1M | $571.4K | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $0 | $-164.0K | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-34M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-11M | $-14M | $-60M | $-8M | $-46M | $-52M | $-1M | $50M | $-14M | $-13M | $-5M | |
| CapEx | · | · | $171.0K | $1M | $949.0K | $3M | $2M | $2M | $2M | $560.0K | $620.7K | $267.4K | |
| Investing Cash Flow | · | · | $12M | $-21M | $-949.0K | $39M | $10M | $-9M | $-46M | · | · | · | |
| Stock Issued | · | · | $20M | $7M | $38M | $10M | · | · | · | · | $26M | $12M | |
| Net Stock Activity | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-660.0K | $87M | $5M | $7M | $59M | $10M | $32M | $49M | $4M | · | · | · | |
| Net Change in Cash | $-26M | $76M | $-9M | $-79M | $47M | $8M | $-13M | $37M | $9M | $6.0K | $11M | $15M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $51.7K | |
| Free Cash Flow | · | · | · | $-61M | · | $-49M | $-55M | $-3M | $48M | · | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1490.4% | · | · | -167.8% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| Net Margin | -1610.6% | · | · | -128.5% | · | -127.0% | -55.0% | -91.9% | -69.8% | · | · | · | |
| Pretax Margin | -1610.6% | · | · | -128.5% | · | -126.4% | -55.0% | -93.0% | -65.5% | · | · | · | |
| EBITDA Margin | -1490.4% | · | · | -157.1% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| ROA | -56.5% | -36.4% | · | -26.7% | · | -30.3% | -17.9% | -21.8% | -25.4% | · | · | · | |
| ROE | -110.1% | 140.6% | · | -92.1% | · | -99.7% | -70.8% | -59.3% | -96.0% | · | · | · | |
| ROIC | -137.9% | -22.5% | · | -155.7% | · | -109.8% | -52.9% | -76.3% | -135.1% | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 7.3 | · | 2.0 | · | 3.4 | 4.3 | 2.8 | 2.0 | · | · | · | |
| Quick Ratio | 5.1 | 7.0 | · | 1.8 | · | 3.3 | 4.1 | 2.7 | 1.9 | · | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.2 | · | 0.2 | 0.3 | 0.2 | 0.4 | · | · | · | |
| Receivables Turnover | 14.5 | · | · | 5.7 | · | 6.9 | 9.8 | 3.2 | 3.2 | · | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.26 | $5.69 | · | $0.37 | · | $0.55 | $0.93 | $0.74 | $0.26 | · | · | · | |
| Revenue / Share | $0.23 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.22 | $-4.87 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $4.68 | $7.59 | · | $0.52 | · | $1.26 | $1.13 | $1.38 | $0.84 | · | · | · | |
| EPS (TTM) | $-3.71 | $-7.83 | $2.17 | $-0.70 | $-0.71 | $-0.68 | · | · | · | · | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 65.3% | -17.6% | 7.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 13.4% | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| Net Income TTM | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| Market Cap | $1.30B | $132M | · | $6.20B | · | $11.20B | $15.99B | $11.52B | $27.19B | · | · | · | |
| P/E | -28.2 | -1.5 | 6.7 | -118.9 | -425.9 | -294.1 | · | · | · | · | · | · | |
| P/S | 66.2 | 6.8 | · | 239.4 | · | 382.0 | 345.5 | 396.0 | 1075.8 | · | · | · | |
| P/B | 46.3 | 2.1 | · | 222.0 | · | 361.0 | 311.4 | 288.6 | 2359.9 | · | · | · | |
| P / Tangible Book | 46.3 | 2.1 | · | · | 430.3 | 361.0 | · | · | · | · | · | · | |
| P / Cash Flow | -51.8 | -12.2 | · | -103.5 | · | -244.0 | -304.8 | -10809.9 | 546.5 | · | · | · | |
| P / FCF | · | · | · | -101.7 | · | -230.4 | -291.1 | -4169.1 | 568.8 | · | · | · | |
| Earnings Yield | -3.5% | -65.2% | 14.9% | -0.84% | -0.23% | -0.34% | · | · | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | $0 | $53.0K | · | $20M | $20M | $2M | $6M | $5M | |
| R&D Expense | $12M | $9M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $984.0K | $-29M | $10M | $14M | $13M | $13M | $14M | |
| SG&A Expense | $9M | $6M | $4M | $4M | $4M | $4M | $2M | $2M | $1M | $775.0K | $-11M | $7M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $21M | $15M | $11M | $10M | $9M | $8M | $4M | $5M | $3M | $2M | $-55M | $31M | $18M | $17M | $17M | $18M | |
| Operating Income | $-21M | $-15M | $-11M | $-10M | $-9M | $-8M | $-4M | $-5M | $-3M | $-2M | $13M | $-12M | $2M | $-16M | $-12M | $-12M | |
| Other Non-op | $-8.0K | $-32.0K | $-92.0K | $34.0K | $561.0K | $224.0K | $-175.0K | $-20.0K | $64.0K | $0 | $424.0K | $506.0K | $-161.0K | $-57.0K | $-325.0K | $723.0K | |
| Pretax Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | $39M | $-11M | $4M | $-13M | $-8M | $-10M | |
| EPS (Basic) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $21.41 | $-8.70 | $3.63 | $-14.15 | $-0.11 | $-0.13 | |
| EPS (Diluted) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $20.50 | $-8.70 | $3.62 | · | · | · | |
| Shares (Basic) | 14,356,219 | 13,085,271 | · | 11,064,282 | 11,052,741 | 11,013,697 | · | 1,770,167 | 1,770,167 | 1,770,167 | · | 1,236,000 | 1,095,000 | 931,000 | · | 74,397,000 | |
| Shares (Diluted) | 14,356,219 | 13,085,271 | · | 11,064,282 | 11,052,741 | 11,013,697 | · | 1,770,167 | 1,770,167 | 1,770,167 | · | 1,236,000 | 1,098,000 | · | · | · | |
| EBITDA | $-21M | $-15M | · | $-10M | $-9M | $-8M | · | $-3M | $-4M | $-5M | · | $-12M | $2M | $-15M | · | $-12M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $188M | $206M | $58M | $64M | $70M | $76M | $84M | $19M | $20M | $19M | $7M | $33M | $45M | $40M | $39M | $48M | |
| Short-term Investments | $63M | $55M | · | · | · | · | · | $0 | $0 | $0 | · | $12M | $10M | $9M | $21M | $21M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $358.0K | $373.0K | $1M | $2M | $0 | $1M | $952.0K | $1M | $6M | $829.0K | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $280.0K | $649.0K | $3M | $198.0K | $9M | $11M | $11M | $3M | $8M | |
| Current Assets | $253M | $263M | $59M | $67M | $74M | $79M | $88M | · | · | · | $8M | $59M | $66M | $61M | $73M | $79M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $0 | $16M | $17M | $17M | $16M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | $27M | $27M | $27M | $24M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | $11M | $10M | $10M | $8M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $287.0K | $1M | $1M | $1M | $1M | |
| Total Assets | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Accounts Payable | $7M | $5M | $5M | $3M | $5M | $4M | $5M | $801.0K | $969.0K | $2M | $936.0K | $3M | $8M | $6M | $4M | $4M | |
| Current Liabilities | $12M | $9M | $11M | $10M | $10M | $9M | $12M | $4M | $6M | $8M | $2M | $29M | $34M | $43M | $37M | $34M | |
| Capital Leases | $318.0K | $375.0K | $431.0K | · | · | · | $0 | · | · | · | · | $0 | $12M | $12M | $12M | $11M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Total Liabilities | $37M | $31M | $32M | $28M | $26M | $24M | $26M | · | · | · | $11M | $29M | $47M | $67M | $68M | $63M | |
| Common Stock | $14.0K | $14.0K | $12.0K | $11.0K | $11.0K | $11.0K | $11.0K | $1.0K | $1.0K | $1.0K | $0 | $99.0K | $99.0K | $74.0K | $74.0K | $74.0K | |
| Paid-in Capital | $390M | $383M | $163M | $161M | $159M | $157M | $156M | $343M | $343M | $342M | $2M | $341M | $340M | $319M | $319M | $317M | |
| Retained Earnings | $-173M | $-151M | $-135M | $-123M | $-111M | $-102M | $-94M | $-326M | $-323M | $-320M | $-76M | $-310M | $-300M | $-304M | $-290M | $-282M | |
| AOCI | $89.0K | $95.0K | $83.0K | $104.0K | $-111.0K | $-3.0K | $3.0K | $-316.0K | $-436.0K | $-346.0K | $0 | $-339.0K | $-137.0K | $-426.0K | $-254.0K | $524.0K | |
| Stockholders' Equity | $217M | $232M | $28M | $39M | $48M | $56M | $63M | $16M | $19M | $22M | $-74M | $31M | $40M | $15M | $28M | $36M | |
| Liabilities + Equity | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Shares Outstanding | 14,395,705 | 14,313,659 | 12,380,933 | 11,088,329 | 11,059,665 | 11,021,389 | 11,012,105 | 1,320,240 | 1,320,240 | 1,236,688 | 1,770,167 | · | 98,851,927 | 74,519,103 | 74,519,103 | 74,406,253 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $-30.0K | · | $739.0K | $758.0K | $605.0K | $575.0K | $767.0K | |
| Stock-based Comp | $5M | $3M | $2M | $2M | $1M | $1M | $268.0K | $-331.0K | $-109.0K | $146.0K | $-2M | $966.0K | $1M | $884.0K | $949.0K | $974.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-13M | $-11M | $-5M | $-8M | $-5M | $-7M | $-5M | $3M | $4M | $-1M | $20M | $-10M | $-13M | $-11M | $-13M | $-9M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $69.0K | $67.0K | $48.0K | $-11.0K | $34.0K | |
| Investing Cash Flow | $-7M | $-55M | · | · | $0 | $0 | · | $142.0K | $2M | $9M | · | $-2M | $-1M | $12M | $1M | $5M | |
| Stock Issued | $0 | $230M | · | · | $0 | $0 | · | $0 | · | · | · | $0 | $20M | $0 | $0 | $282.0K | |
| Net Stock Activity | · | $230M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $215M | $-49.0K | $242.0K | $349.0K | $-1M | $75M | $12M | $10M | $0 | $-15M | $0 | $20M | $0 | $93.0K | $282.0K | |
| Net Change in Cash | $-19M | $148M | $-6M | $-7M | $-5M | $-8M | $69M | $5M | $5M | $-1M | $-3M | $-12M | $5M | $1M | $-10M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $-11M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10005.7% | · | -60.5% | 10.3% | -801.2% | · | -226.6% | |
| Net Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | -9230.2% | · | -55.1% | 19.8% | -680.9% | · | -181.3% | |
| Pretax Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10062.3% | · | -60.5% | 10.3% | -769.9% | · | -226.6% | |
| ROA | -13.4% | -9.2% | · | -25.9% | -19.2% | -15.0% | · | -7.2% | -6.4% | -8.8% | · | -13.6% | 3.9% | -12.0% | · | -7.4% | |
| ROE | -16.5% | -10.9% | · | -41.3% | -28.5% | -21.1% | · | -12.3% | -12.1% | -26.2% | · | -32.5% | 9.4% | -38.3% | · | -21.7% | |
| ROIC | -9.9% | -6.4% | · | -26.3% | -19.4% | -14.2% | · | · | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.2 | 28.9 | · | 6.5 | 7.7 | 8.8 | · | · | · | · | · | 2.0 | 1.9 | 1.4 | · | 2.3 | |
| Quick Ratio | 21.0 | 28.7 | · | 6.2 | 7.3 | 8.4 | · | 4.6 | 3.3 | 2.8 | · | 1.6 | 1.6 | 1.2 | · | 2.1 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.2 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 3.4 | 0.9 | 0.8 | · | 0.0 | 0.0 | 0.0 | · | 20.8 | 18.1 | 1.4 | · | 1.4 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.06 | $16.23 | · | $3.49 | $4.32 | $5.04 | · | $12.32 | $14.17 | $17.76 | · | · | $0.41 | $0.21 | · | $0.48 | |
| Revenue / Share | $0.14 | $0.08 | · | $0.06 | $0.06 | $0.07 | · | $0.00 | $0.00 | · | · | · | $0.23 | · | · | · | |
| Cash Flow / Share | · | $-0.83 | · | · | · | $-0.61 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $13.05 | $14.42 | · | $5.73 | $6.37 | $6.86 | · | $14.67 | $14.95 | $15.43 | · | · | $0.45 | $0.53 | · | $0.65 | |
| EPS (TTM) | $-4.83 | $-4.17 | · | $-2.51 | $-5.42 | $-7.03 | · | $12.55 | $7.79 | $13.88 | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $47M | $33M | $17M | · | $28M | |
| Net Income TTM | $-62M | $-49M | · | $-33M | $-28M | $-23M | · | $25M | $21M | $29M | · | $-28M | $-27M | $-41M | · | $-35M | |
| Market Cap | $2.20B | $1.78B | · | $695M | $249M | $308M | · | $22M | $13M | $18M | · | · | $1.31B | $5.82B | · | $6.85B | |
| P/E | -31.6 | -29.9 | · | -25.0 | -4.2 | -4.0 | · | 1.3 | 1.3 | 1.1 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | 39.5 | 345.3 | · | 240.2 | |
| P/B | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Tangible Book | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Cash Flow | · | -164.2 | · | · | · | -45.6 | · | · | · | -2.6 | · | · | · | -529.1 | · | · | |
| Earnings Yield | -3.2% | -3.4% | · | -4.0% | -24.1% | -25.1% | · | 75.7% | 79.4% | 94.8% | · | · | · | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | · | · | $43M | $26M | $31M |
| Margin Operasi % | -1490.4% | · | · | -167.8% | · |
| Laba Bersih | $-42M | $-17M | $19M | $-33M | $-46M |
| EPS Dilusian | $-3.71 | $-7.83 | $2.17 | · | $-0.71 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 5.2 | 7.3 | · | 2.0 | · |
| Rasio Cepat | 5.1 | 7.0 | · | 1.8 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | · | · | · | $-61M | · |
Pemilik institusional (13F) 210 pengaju · $2.2B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
210
Nilai yang dipegang
$2.2B
Posisi baru
35
Posisi yang keluar
19
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 35 (-35 vs Kuartal sebelumnya) | 19 (-3 vs Kuartal sebelumnya) | 93 (+24 vs Kuartal sebelumnya) | 45 (+15 vs Kuartal sebelumnya) | +820K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $173.512.745 | 1.135.406 | 7,97% | Saham |
| JENNISON ASSOCIATES LLC | $146.801.795 | 960.619 | 6,75% | Saham |
| BlackRock, Inc. | $140.343.317 | 918.357 | 6,45% | Saham |
| Frazier Life Sciences Management, L.P. | $134.848.368 | 882.400 | 6,20% | Saham |
| First Light Asset Management, LLC | $117.961.911 | 771.901 | 5,42% | Saham |
| BVF INC/IL | $102.815.615 | 672.789 | 4,72% | Saham |
| STATE STREET CORP | $99.817.745 | 653.172 | 4,59% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $78.517.999 | 513.794 | 3,61% | Saham |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $73.175.272 | 478.833 | 3,36% | Saham |
| FEDERATED HERMES, INC. | $66.173.352 | 433.015 | 3,04% | Saham |
| VANGUARD GROUP INC | $58.679.676 | 560.616 | 2,70% | Saham |
| Woodline Partners LP | $48.522.948 | 317.517 | 2,23% | Saham |
| ORBIMED ADVISORS LLC | $44.678.455 | 292.360 | 2,05% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $42.213.033 | 276.164 | 1,94% | Saham |
| Siren, L.L.C. | $39.348.858 | 257.485 | 1,81% | Saham |
| PRIMECAP MANAGEMENT CO/CA/ | $39.149.734 | 256.182 | 1,80% | Saham |
| EVENTIDE ASSET MANAGEMENT, LLC | $35.375.385 | 231.484 | 1,63% | Saham |
| EMERALD ADVISERS, LLC | $35.070.051 | 229.486 | 1,61% | Saham |
| FMR LLC | $32.831.927 | 214.841 | 1,51% | Saham |
| ALLIANCEBERNSTEIN L.P. | $31.557.391 | 253.168 | 1,45% | Saham |
| MPM BIOIMPACT LLC | $31.179.406 | 204.027 | 1,43% | Saham |
| GOLDMAN SACHS GROUP INC | $30.795.370 | 201.514 | 1,42% | Saham |
| MORGAN STANLEY | $27.725.827 | 181.428 | 1,27% | Saham |
| First Turn Management, LLC | $23.908.689 | 156.450 | 1,10% | Saham |
| Bellevue Group AG | $23.687.100 | 155.000 | 1,09% | Saham |
| Caption Management, LLC | $21.394.800 | 140.000 | 0,98% | Opsi jual |
| EMERALD MUTUAL FUND ADVISERS TRUST | $19.843.219 | 129.847 | 0,91% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.707.973 | 128.962 | 0,91% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.430.092 | 120.600 | 0,85% | Opsi beli |
| Aberdeen Group plc | $18.374.771 | 120.238 | 0,84% | Saham |
| NORTHERN TRUST CORP | $14.853.034 | 97.193 | 0,68% | Saham |
| NEXTBio Capital Management LP | $13.739.893 | 89.909 | 0,63% | Saham |
| Clio Asset Management LLC | $13.194.937 | 86.343 | 0,61% | Saham |
| NEUBERGER BERMAN GROUP LLC | $12.700.411 | 83.107 | 0,58% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.706.012 | 76.600 | 0,54% | Opsi jual |
| VANGUARD FIDUCIARY TRUST CO | $11.307.916 | 73.995 | 0,52% | Saham |
| UBS Group AG | $11.083.424 | 72.526 | 0,51% | Saham |
| Avidity Partners Management LP | $10.697.400 | 70.000 | 0,49% | Saham |
| AWM Investment Company, Inc. | $10.608.153 | 69.416 | 0,49% | Saham |
| SEVEN GRAND MANAGERS, LLC | $9.169.200 | 60.000 | 0,42% | Saham |
| Clearbridge Investments, LLC | $9.068.458 | 59.341 | 0,42% | Saham |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $8.713.159 | 69.901 | 0,40% | Saham |
| BANK OF AMERICA CORP /DE/ | $8.336.942 | 54.554 | 0,38% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $8.140.721 | 53.270 | 0,37% | Saham |
| MILLENNIUM MANAGEMENT LLC | $7.979.038 | 52.212 | 0,37% | Saham |
| Ensign Peak Advisors, Inc | $7.894.681 | 51.660 | 0,36% | Saham |
| HSBC HOLDINGS PLC | $7.641.156 | 50.001 | 0,35% | Saham |
| Nicholas Investment Partners, LP | $7.597.905 | 49.718 | 0,35% | Saham |
| Balyasny Asset Management L.P. | $6.805.992 | 44.536 | 0,31% | Saham |
| Lisanti Capital Growth, LLC | $6.567.440 | 42.975 | 0,30% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Kaupinen Wes, Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Christine L. Kaupinen, Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Michael Christopher | 20 Des. 2024 | 14,60% | Pengajuan awal | · | SEC |
| Biotechnology Value Fund, L.P., BVF I GP LLC, Biotechnology Value Fund II, L.P., BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP Holdings LLC, BVF Partners L.P., BVF Inc., Mark N. Lampert ×2 pengajuan | 17 Agu 2023 | · | Pengajuan awal | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×10 pengajuan | 27 Sep. 2018 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 34 orang dalam · 16 pejabat · 19 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Kaupinen Wes | President and CEO | 5 Feb. 2026 A | · | 0 | 0 | $0 |
| Stephen S. Yoder | Chief Executive Officer | 24 Feb. 2023 A | 6.000 | 0 | 0 | $0 |
| Matthew E Korenberg | CFO, Treasurer | 12 Juni 2026 M | 1.000 | 0 | 0 | $0 |
| Thomas Bures | Chief Financial Officer | 24 Feb. 2023 A | · | 0 | 0 | $0 |
| Allan Reine | Chief Financial Officer | 26 Feb. 2019 A | 65.000 | 0 | 0 | $0 |
| Darlene M Deptula-Hicks | SVP, Chief Financial Officer | 13 Juni 2016 P | 5.000 | 0 | 0 | $0 |
| Kathleen Goin | Chief Operating Officer | 16 Sep. 2026 M | 0 | 0 | 33 | $-5.506.479 |
| Ashley Hartmann Kline | Chief Commercial Officer | 5 Feb. 2026 A | · | 0 | 0 | $0 |
| Jeffrey S Martini | Chief Scientific Officer | 5 Feb. 2026 A | · | 0 | 0 | $0 |
| PALVELLA THERAPEUTICS, INC. | Chief Scientific Officer | 5 Feb. 2025 A | · | 0 | 0 | $0 |
| Ahmed Mousa | Chief Business Officer | 24 Feb. 2023 A | · | 0 | 0 | $0 |
| Shane Olwill | Chief Development Officer | 24 Feb. 2023 A | 4.638 | 0 | 0 | $0 |
| Hitto Kaufmann | Chief Scientific Officer | 24 Feb. 2023 A | · | 0 | 0 | $0 |
| Tim Demuth | Chief Medical Officer | 13 Mei 2022 P | 6.000 | 0 | 0 | $0 |
| Louis Matis | Chief Development Officer | 26 Feb. 2019 A | 10.000 | 0 | 0 | $0 |
| Claude Knopf | Chief Business Officer | 28 Nov. 2016 A | · | 0 | 0 | $0 |
| George M Jenkins | Direktur | 15 Sep. 2026 S | 160.116 | 2 | 9 | $-3.617.215 |
| Christopher P Kiritsy | Direktur | 2 Sep. 2026 M | 250 | 0 | 1 | $-49.141 |
| Matthew Pauls | Direktur | 29 Juni 2026 A | · | 0 | 0 | $0 |
| Tadd S. Wessel | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| John Doux | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| Todd C Davis | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| Elaine J Heron | Direktur | 10 Juni 2026 A | 47.812 | 1 | 0 | $300.000 |
| James A Geraghty | Direktur | 12 Des. 2024 D | 0 | 0 | 0 | $0 |
| Maya R. Said | Direktur | 21 Juni 2023 A | · | 0 | 0 | $0 |
| Ann Barbier | Direktur | 21 Juni 2023 A | · | 0 | 0 | $0 |
| Michael Richman | Direktur | 21 Juni 2023 A | · | 0 | 0 | $0 |
| Peter A Kiener | Direktur | 21 Juni 2023 A | · | 0 | 0 | $0 |
| Matthew L Sherman | Direktur | 21 Juni 2023 A | · | 0 | 0 | $0 |
| Jean-Pierre Bizzari | Direktur | 25 Jan. 2020 A | · | 0 | 0 | $0 |
| Steven Prelack | Direktur | 25 Jan. 2019 A | · | 0 | 0 | $0 |
| Julian Adams | Direktur | 25 Jan. 2018 A | · | 0 | 0 | $0 |
| Chau Quang Khuong | Direktur | 25 Okt. 2017 A | 65.398 | 0 | 0 | $0 |
| Aquilo Capital Management, LLC | Pemilik 10% | 21 Juli 2020 S | 3.675.530 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 21 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,86% | 2.856 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,39% | 13.887 NS | 31 Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,18% | 22.955 SH | 19 Agu 2026 | Harian |
| PWS · Pacer Funds Trust | 0,11% | 190 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,11% | 103.168 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 11.762 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,05% | 280.820 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 63.184 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,05% | 5.240 NS | 31 Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 1.583 SH | 11 Sep. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 4.864 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 113.556 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,02% | 30.157 SH | 19 Agu 2026 | Harian |
| WSML · iShares Trust | 0,02% | 674 SH | 10 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 3.420 SH | 3 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 14.740 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,00% | 218 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 388.390 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 904 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 450 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 1.075 SH | 11 Sep. 2026 | Harian |
PVLA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 22 analis
BELI
Target median
$232.00
+75,1%
6 27,3%
Beli Kuat
15 68,2%
Beli
1 4,5%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
15 analis · 2026-09-28Target rata-rata $230.53 +74,0%
← Di bawah semua target
Harga saat ini $132.47
Rendah$205.00
Rata-rata$230.53
Tinggi$270.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | · |
| GENB | · | · | · | · | · | · |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | · |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 4, 2026